What is Sophim?
Sophim operates as an independent entity dedicated to the sophisticated production of oils and natural ingredients tailored for the cosmetic, personal care, and pharmaceutical sectors. By leveraging sustainable chemistry and high-purity extraction processes, the company has carved out a critical niche in the supply chain for high-end consumer goods and medical formulations. Its market position is defined by a commitment to quality and traceability, ensuring that raw materials meet the rigorous standards required by international regulatory bodies in the beauty and health industries.
How much funding has Sophim raised?
Sophim has raised a total of $21.3M across 1 funding round:
Other Financing Round
$21.3M
Other Financing Round (2023): $21.3M with participation from Smalt Capital
Key Investors in Sophim
Smalt Capital
Smalt Capital is a financial services firm based in Marseille, France, specializing in private equity operations designed to accelerate business growth and operational maturity.
What's next for Sophim?
With this recent capital backing, Sophim is well-positioned to scale its operational infrastructure and expand its research and development initiatives. The strategic focus will likely shift toward enhancing production capacity to meet the rising global demand for clean-label and sustainable ingredients. By optimizing its supply chain and investing in innovative extraction technologies, the company aims to strengthen its competitive advantage, potentially exploring new geographic markets and diversifying its portfolio of natural derivatives to serve a broader spectrum of enterprise-level clients in the life sciences and personal care domains.
See full Sophim company page
